Sign In
Buy SILO
$6.13
+5.78 (+1,650.93%)
At Close: Jun 03, 2026
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
08:05am, Thursday, 07'th May 2026
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines
Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
09:08am, Wednesday, 29'th Apr 2026
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
09:08am, Wednesday, 29'th Apr 2026
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment SARASOTA, Fla, April 29, 2026 (GLOBE NEWSWIRE) -- Silo Pharm
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update
05:38am, Monday, 27'th Apr 2026
Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 522,541 share
Launch of Dedicated AI Subsidiary Positions Company for New Revenue Streams While Advancing PTSD Program Toward Phase 1 SARASOTA, FL, April 22, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO
SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health Therapies SARASOTA, Fla. , April 20, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: SILO), a developmenta
Silo Pharma Rallies After Securing Key Patent Allowance
09:40am, Tuesday, 07'th Apr 2026
Silo said the European Patent Office issued a Rule 71(3) communication indicating its intent to grant a patent for the application, which the company has an exclusive license from Columbia University.
Meanwhile, Iran has submitted a 10-point response to the U.S. peace proposals, which a U.S. official described as "maximalist", citing the Iranian state news agency IRNA.
Silo Pharma (SILO) Stock Soars 47% After European Patent Win: What You Should Know
02:11am, Tuesday, 07'th Apr 2026
Silo Pharma stock jumps after-hours after European patent allowance for PTSD prevention therapy targeting 5-HT4 pathway.
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
04:15pm, Monday, 06'th Apr 2026
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SIL
Contrasting Palvella Therapeutics (NASDAQ:PVLA) & Silo Pharma (NASDAQ:SILO)
01:20am, Saturday, 14'th Mar 2026
Silo Pharma (NASDAQ: SILO - Get Free Report) and Palvella Therapeutics (NASDAQ: PVLA - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two
Silo Pharma Announces Share Buyback Program
04:15pm, Monday, 23'rd Feb 2026
Sarasota, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with p
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
08:28am, Wednesday, 18'th Feb 2026
SARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulat
Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update
04:34am, Thursday, 05'th Feb 2026
Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 518,127 shares, a drop of 12.
Silo Pharma (NASDAQ:SILO) Stock Price Up 3.6% – Still a Buy?
02:44am, Friday, 23'rd Jan 2026
Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) shares traded up 3.6% during trading on Thursday. The stock traded as high as $0.3754 and last traded at $0.3689. 45,852 shares traded hands during m
